Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

@article{Baxter2005AcquiredMO,
  title={Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders},
  author={E. Baxter and L. M. Scott and P. Campbell and Clare East and A. Green},
  journal={The Lancet},
  year={2005},
  volume={365},
  pages={1054-1061}
}
  • E. Baxter, L. M. Scott, +2 authors A. Green
  • Published 2005
  • Biology, Medicine
  • The Lancet
  • BACKGROUND Human myeloproliferative disorders form a range of clonal haematological malignant diseases, the main members of which are polycythaemia vera, essential thrombocythaemia, and idiopathic myelofibrosis. [...] Key MethodMETHODS We obtained DNA samples from patients with polycythaemia vera, essential thrombocythaemia, or idiopathic myelofibrosis. The coding exons of JAK2 were bidirectionally sequenced from peripheral-blood granulocytes, T cells, or both.Expand Abstract
    3,099 Citations
    Evaluation of Common Genetic Disorders in Myeloproliferative Neoplasms
    • 1
    • Highly Influenced
    The V617F JAK2 mutation and the myeloproliferative disorders
    • 32
    JAK2 and MPL Mutations in Myeloproliferative Neoplasms
    • 16
    JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis.
    • 1,114
    • PDF

    References

    SHOWING 1-10 OF 407 REFERENCES
    Chronic myeloproliferative disorders.
    • 113
    • PDF